Oesophageal Cancer Trial, Recruiting (NCT06713993)

Oesophageal Cancer Trial, Recruiting NCT06713993 Sponsor: Semmelweis University Condition: Oesophageal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06713993 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Oesophageal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are over 18 years old
People who have been recently diagnosed with a new tumour of the oesophagus (food pipe) or the area where the oesophagus meets the stomach
People who are scheduled for planned surgery aimed at removing the cancer completely (either open surgery or keyhole surgery)
People who have not yet received any cancer treatment for their current diagnosis

Who may not be able to join:

People who have not given their consent to participate
People who are unable or unwilling to cooperate with the study requirements
People for whom an MRI scan is not medically safe — in those cases, the heart MRI portion of the study would not be performed (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +36208259039

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06713993

Sponsor: Semmelweis University

Phase: Not Applicable

Status: Recruiting

Condition: Oesophageal Cancer

Trial contact: +36208259039

More information: https://clinicaltrials.gov/study/NCT06713993

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are over 18 years old
People who have been recently diagnosed with a new tumour of the oesophagus (food pipe) or the area where the oesophagus meets the stomach
People who are scheduled for planned surgery aimed at removing the cancer completely (either open surgery or keyhole surgery)
People who have not yet received any cancer treatment for their current diagnosis

Who may not be able to join:

People who have not given their consent to participate
People who are unable or unwilling to cooperate with the study requirements
People for whom an MRI scan is not medically safe — in those cases, the heart MRI portion of the study would not be performed (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Semmelweis University

Registry

ClinicalTrials.gov

Start date

10 September 2024

Est. completion

30 September 2029

Where this trial is recruiting

🇭🇺 Hungary

Primary endpoints

Changes in cardiac function: cardiac MR scan; Changes in coronary status: coronary CT scan; Morbidity (early and long term) classified after Clavien-Dindo.; Early and late mortality; Length of hospital stay; Number of days spent on ICU (Intensive care unit); Changes in physical performance: 6-minute walk test (6MWT); Changes in physical performance: hand grip strength test; Changes in physical performance: time up and go test; Changes in ECOG (Eastern Cooperative Oncology Group) performance status; Change in nutritional status, risk of malnutrition and nutritional ability: MUST (Malnutrition U...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov